Phillip M Freeman

发表

Mechanical circulatory support for refractory out-of-hospital cardiac arrest: a Danish nationwide multicenter study

C. Terkelsen, C. Hassager, J. Kjaergaard, 2021, Critical Care.

Rationale and design of SAVI-AoS: A physiologic study of patients with symptomatic moderate aortic valve stenosis and preserved left ventricular ejection fraction

W. Qureshi, Dae‐Hee Kim, Jung‐Min Ahn, 2022, International journal of cardiology. Heart & vasculature.

Increased morbidity, mortality and length of in-hospital stay for patients with acute coronary syndrome with pre-morbid psychiatric diagnoses.

A. Lacey, Dave Smith, M. Protty, 2017, International journal of cardiology.

Changes in platelet function independent of pharmacotherapy following coronary intervention in non-ST-elevation myocardial infarction patients.

V. O’Donnell, T. Kinnaird, Richard A Anderson, 2015, Atherosclerosis.

Vascular impact of progenitor cell mobilisation for cardiac repair post-myocardial infarction

J. Halcox, Phillip M Freeman, 2009, Heart.

Severe symptomatic aortic stenosis: medical therapy and transcatheter aortic valve implantation (TAVI)—a real-world retrospective cohort analysis of outcomes and cost-effectiveness using national data

Richard A Anderson, A. Lacey, O. Aldalati, 2016, Open Heart.

Mechanical circulatory support for refractory out-of-hospital cardiac arrest: a Danish nationwide multicenter study

C. Terkelsen, C. Hassager, J. Kjaergaard, 2021, Critical Care.

Saphenous vein graft percutaneous coronary intervention via radial artery access: safe and effective with reduced hospital length of stay.

A. Zaman, V. Kunadian, T. Kinnaird, 2012, American Heart Journal.

Routine revascularization with percutaneous coronary intervention in patients with coronary artery disease undergoing transcatheter aortic valve implantation - the third Nordic Aortic Valve Intervention Trial - NOTION-3.

C. Terkelsen, K. Veien, T. Engstrøm, 2022, American heart journal.

Statins for secondary prevention: clinical use in patients with acute coronary syndrome in Wales.

A. Lacey, M. Protty, J. Hayes, 2017, Future cardiology.

Discharge after Primary Angioplasty at 24 h: Feasible and Safe or a Step Too Far?

P. Meier, A. Khavandi, Phillip M Freeman, 2013, Cardiology.

Chronic anemia and non-ST elevation acute coronary syndrome – double jeopardy

Richard A Anderson, Phillip M Freeman, J. Berrill, 2016, Current medical research and opinion.

Polymer-free biolimus-coated stents versus ultrathin-strut biodegradable polymer sirolimus-eluting stents: two-year outcomes of the randomised SORT OUT IX trial.

M. Maeng, E. Christiansen, B. Raungaard, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Five-Year Clinical Outcome of the Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent Compared to the Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: From the SORT OUT VII Trial

C. Terkelsen, K. Veien, M. Maeng, 2021, Circulation. Cardiovascular interventions.

Combinations of bleeding and ischemic risk and their association with clinical outcomes in acute coronary syndrome.

A. Zaman, P. Myint, T. Kinnaird, 2019, International journal of cardiology.

Severe symptomatic aortic stenosis: medical therapy and transcatheter aortic valve implantation (TAVI)-a real-world retrospective cohort analysis of outcomes and cost-effectiveness using national data.

Richard A Anderson, A. Lacey, O. Aldalati, 2016, Open heart.

Statins for primary prevention in practice: clinical use in Wales and the NICE guideline effect

A. Lacey, M. Protty, J. Hayes, 2016, British journal of clinical pharmacology.

Severe symptomatic aortic stenosis: medical therapy and transcatheter aortic valve implantation (TAVI)—a real-world retrospective cohort analysis of outcomes and cost-effectiveness using national data

Richard A Anderson, A. Lacey, O. Aldalati, 2016, Open Heart.